This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Reprints and Permissions Copyright Information Books from ASM Press MicrobeWorld Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Carlin, J. M. Articles by Weller, J. B. Search for Related Content PubMed PubMed Citation Articles by Carlin, J. M. Articles by Weller, J. B.

 Previous Article  |  Next Article 

Infect. Immun., May 1995, 1870-1875, Vol 63, No. 5
Copyright © 1995, American Society for Microbiology

Potentiation of interferon-mediated inhibition of Chlamydia infection by interleukin-1 in human macrophage cultures

JM Carlin and JB Weller
Department of Microbiology, Miami University, Oxford, Ohio 45056, USA.

One mechanism by which interferons (IFNs) can inhibit chlamydial infection is by the induction of the enzyme indoleamine 2,3-dioxygenase (IDO), which restricts the availability of tryptophan, which is required for chlamydial growth. Other immunomodulating agents, including interleukin-1 (IL-1), can interact synergistically with IFNs, resulting in increased IDO activity in macrophages. The objectives of this study were to establish that IL-1 can enhance IFN-mediated inhibition of chlamydial growth by increasing the amount of IDO activity induced by IFNs and to identify immunomodulatory agents in culture supernatants from chlamydia-infected macrophages that interact synergistically with IFNs in restricting chlamydial growth. Monocyte- derived macrophages were treated with IL-1 combined with gamma IFN (IFN- gamma) or IFN-beta. The ability of treated cells to support the growth of Chlamydia psittaci was directly related to the amount of IDO activity induced; as IDO activity increased, so did inhibition of chlamydial growth. Furthermore, concentrations of IFNs were identified at which little IDO activity was induced and chlamydial growth was permitted yet which in the presence of IL-1 resulted in increased IDO activity and restriction of chlamydial growth. The addition of exogenous tryptophan reversed the effect of combined IFN and IL-1 treatment, indicating that IDO activity induced by combined cytokine treatment was responsible for chlamydial inhibition. Supernatants from chlamydia-infected macrophages were capable of potentiating IDO induction by IFN-gamma and of restricting the growth of C. psittaci. Antibody to IL-1 beta neutralized the potentiating effects of supernatants from chlamydia-infected cells on both IDO induction and chlamydial inhibition. Thus, IL-1 produced in response to chlamydial infection may contribute to the elimination of the infection.

This article has been cited by other articles:

• Schmeck, B., Beermann, W., N'Guessan, P. D., Hocke, A. C., Opitz, B., Eitel, J., Dinh, Q. T., Witzenrath, M., Krull, M., Suttorp, N., Hippenstiel, S. (2008). Simvastatin Reduces Chlamydophila pneumoniae-Mediated Histone Modifications and Gene Expression in Cultured Human Endothelial Cells. Circ. Res. 102: 888-895 [Abstract] [Full Text]  
• Vanover, J., Sun, J., Deka, S., Kintner, J., Duffourc, M. M., Schoborg, R. V. (2008). Herpes simplex virus co-infection-induced Chlamydia trachomatis persistence is not mediated by any known persistence inducer or anti-chlamydial pathway. Microbiology 154: 971-978 [Abstract] [Full Text]  
• Darville, T., Welter-Stahl, L., Cruz, C., Sater, A. A., Andrews, C. W. Jr., Ojcius, D. M. (2007). Effect of the Purinergic Receptor P2X7 on Chlamydia Infection in Cervical Epithelial Cells and Vaginally Infected Mice. J. Immunol. 179: 3707-3714 [Abstract] [Full Text]  
• Shirey, K. A., Jung, J.-Y., Carlin, J. M. (2006). Up-Regulation of Gamma Interferon Receptor Expression Due to Chlamydia-Toll-Like Receptor Interaction Does Not Enhance Signal Transducer and Activator of Transcription 1 Signaling. Infect. Immun. 74: 6877-6884 [Abstract] [Full Text]  
• Rothfuchs, A. G., Trumstedt, C., Mattei, F., Schiavoni, G., Hidmark, A., Wigzell, H., Rottenberg, M. E. (2006). STAT1 Regulates IFN-{alpha}beta- and IFN-{gamma}-Dependent Control of Infection with Chlamydia pneumoniae by Nonhemopoietic Cells.. J. Immunol. 176: 6982-6990 [Abstract] [Full Text]  
• Shirey, K. A., Carlin, J. M. (2006). Chlamydiae Modulate Gamma Interferon, Interleukin-1{beta}, and Tumor Necrosis Factor Alpha Receptor Expression in HeLa Cells. Infect. Immun. 74: 2482-2486 [Abstract] [Full Text]  
• Gervassi, A., Alderson, M. R., Suchland, R., Maisonneuve, J. F., Grabstein, K. H., Probst, P. (2004). Differential Regulation of Inflammatory Cytokine Secretion by Human Dendritic Cells upon Chlamydia trachomatis Infection. Infect. Immun. 72: 7231-7239 [Abstract] [Full Text]  
• Hogan, R. J., Mathews, S. A., Mukhopadhyay, S., Summersgill, J. T., Timms, P. (2004). Chlamydial Persistence: beyond the Biphasic Paradigm. Infect. Immun. 72: 1843-1855 [Full Text]  
• Yang, J., Hooper, W. C., Phillips, D. J., Tondella, M. L., Talkington, D. F. (2003). Induction of Proinflammatory Cytokines in Human Lung Epithelial Cells during Chlamydia pneumoniae Infection. Infect. Immun. 71: 614-620 [Abstract] [Full Text]  
• Rottenberg, M. E., Gigliotti Rothfuchs, A., Gigliotti, D., Ceausu, M., Une, C., Levitsky, V., Wigzell, H. (2000). Regulation and Role of IFN-{gamma} in the Innate Resistance to Infection with Chlamydia pneumoniae. J. Immunol. 164: 4812-4818 [Abstract] [Full Text]  
• Geng, Y., Berencsi, K., Gyulai, Z., Valyi-Nagy, T., Gonczol, E., Trinchieri, G. (2000). Roles of Interleukin-12 and Gamma Interferon in Murine Chlamydia pneumoniae Infection. Infect. Immun. 68: 2245-2253 [Abstract] [Full Text]  
• Matsushima, H., Shirai, M., Ouchi, K., Yamashita, K., Kakutani, T., Furukawa, S., Nakazawa, T. (1999). Lymphotoxin Inhibits Chlamydia pneumoniae Growth in HEp-2 Cells. Infect. Immun. 67: 3175-3179 [Abstract] [Full Text]  
• Airenne, S., Surcel, H.-M., Alakarppa, H., Laitinen, K., Paavonen, J., Saikku, P., Laurila, A. (1999). Chlamydia pneumoniae Infection in Human Monocytes. Infect. Immun. 67: 1445-1449 [Abstract] [Full Text]